1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic information for subjects in each group
HIV(+) HIV(−) P Value Age (yr) 15.3 ± 1.3 15.0 ± 1.6 .54 Sex (male/female) 8:7 13:13 .84 Education level (yr) 7.5 ± 1.2 8.7 ± 1.9 .05 Current CD4 (cells/mL) 605.8 ± 345.0 NA NA Age at first HIV treatment (yr) 9.5 ± 3.4 NA NA HIV treatment duration (mo) 68.3 ± 39.5 NA NA % Treated at younger than 2 yr 13.3 (n = 2) NA NA Plasma viral load (copies/mL) 0–50 NA NA MoCA total score 25.7 ± 3.8 27.1 ± 3.1 .21 MMSE total score 25.8 ± 2.1 27.3 ± 2.4 .05
Note:—NA indicates not applicable or available; MoCa, Montreal Cognitive Assessment; MMSE, Mini-Mental State Examination.